English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [2303]
News [5284]
Articles [130]
Editorials [4]
Conferences [158]
elearning [13]
New hopes for prostate cancer
Prof Cora Sternberg - San Camillo Forlanini Hospital, Rome, Italy
New hopes for prostate cancer ( Prof Cora Sternberg - San Camillo Forlanini Hospital, Rome, Italy )
23 Jun 2011
ASCO 2011: Developments in ovarian cancer therapy
Prof Christian Marth - Innsbruck Medical University, Austria
ASCO 2011: Developments in ovarian cancer therapy ( Prof Christian Marth - Innsbruck Medical University, Austria )
23 Jun 2011
New oncogene target for breast cancer: LMTK3
Prof Justin Stebbing - Imperial College London, UK
New oncogene target for breast cancer: LMTK3 ( Prof Justin Stebbing - Imperial College London, UK )
22 Jun 2011
Olaparib maintenance therapy for ovarian cancer and updates from ICON7
Prof Jonathan Ledermann - UCL Cancer Institute, London, UK
Olaparib maintenance therapy for ovarian cancer and updates from ICON7 ( Prof Jonathan Ledermann - UCL Cancer Institute, London, UK )
22 Jun 2011
Advances in breast cancer research from ASCO 2011
Dr David Miles - Mount Vernon Hospital, London, UK
Advances in breast cancer research from ASCO 2011 ( Dr David Miles - Mount Vernon Hospital, London, UK )
20 Jun 2011
Combining oral targeted therapies shows early anti-tumour activity for advanced...
Dr Jeffrey Infante - Sarah Cannon Research Institute, Nashville, USA
Combining oral targeted therapies shows early anti-tumour activity for advanced melanoma ( Dr Jeffrey Infante - Sarah Cannon Research Institute, Nashville, USA )
20 Jun 2011
Vall d´Hebron Institute of Oncology; advancing personalized and targeted...
Prof José Baselga - Massachusetts General Hospital, Boston, USA; Prof Josep...
Vall d´Hebron Institute of Oncology; advancing personalized and targeted therapies against cancer ( Prof José Baselga - Massachusetts General Hospital, Boston, USA; Prof Josep Tabernero, Vall d´Hebron Institute of Oncology, Barcelona, Spain )
17 Jun 2011
ASCO 2011 highlights
Prof Gordon McVie – ecancer Managing Editor
ASCO 2011 highlights ( Prof Gordon McVie – ecancer Managing Editor )
16 Jun 2011
Advances in understanding the genetic basis of kidney cancer
Prof Tim Eisen - Cambridge Cancer Centre, UK
Advances in understanding the genetic basis of kidney cancer ( Prof Tim Eisen - Cambridge Cancer Centre, UK )
3 Jun 2011
New models in interdisciplinary, translational and clinical research
Prof Alan Nelson - Arizona State University Biodesign Institute, Tempe, USA
New models in interdisciplinary, translational and clinical research ( Prof Alan Nelson - Arizona State University Biodesign Institute, Tempe, USA )
2 Jun 2011
The future of medicine: personalised
Prof Hans Lehrach - Max Planck Institute for Molecular Genetics, Berlin, Germany
The future of medicine: personalised ( Prof Hans Lehrach - Max Planck Institute for Molecular Genetics, Berlin, Germany )
2 Jun 2011
New findings in proteasome inhibitors for myeloma patients
Dr Sagar Lonial (Emory University, Atlanta, USA): Dr Rafael Fonseca (Mayo...
New findings in proteasome inhibitors for myeloma patients ( Dr Sagar Lonial (Emory University, Atlanta, USA): Dr Rafael Fonseca (Mayo Clinic, Arizona, USA): Interviewer - Dr Keith Stewart (Mayo Clinic, Arizona, USA) )
2 Jun 2011
<1...183184185186187...192>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top